New weight loss drug shows promise in early trial
Disease control
Completed
This study tested a new medicine called GV101 to help people with obesity lose weight. 131 healthy but obese adults received different doses of GV101 or a placebo for 16 weeks. The main goal was to see how much weight they lost compared to those on placebo.
Phase: PHASE2 • Sponsor: Graviton Bioscience Corporation • Aim: Disease control
Last updated May 26, 2026 10:35 UTC